About Contact Us Careers

Cardiometabolic Drugs Market - Top Companies and Manufacturers

Request Free Sample Copy

Report ID: 4146
Published Date: Jun 24, 2024
Report Format: PDF, PPT

Buy Now

Companies Dominating the Cardiometabolic Drugs Landscape

GSK plc
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis

Lupin Limited
Merck KGaA
Romark L.C.
Pfizer Inc.
Endo International plc
Bayer AG
Jazz Pharmaceuticals plc
Canopy Growth Corporation
InMed Pharmaceuticals Inc.

Browse Key Market Insights with Data Illustration:

Cardiometabolic Drugs Market Size & Share, Growth Forecasts 2024-2036

In the News

GSK plc acquires the approval from US Food and Drug Administration (FDA) for its Priorix, a vaccine for mumps, measles, and rubella in children 12 months old or above it.
Lupin Limited to merge its path with Yabao Pharmaceutical Co., inc., based in China, to fulfill the escalating demand in the Chinese market for quality drugs with the pediatric formulation.

Author Credits: Radhika Pawar

Report ID: 4146
Published Date: Jun 24, 2024
Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2024, the industry size of cardiometabolic drugs is evaluated at USD 56.29 Billion.

The cardiometabolic drugs market size was valued at USD 53.05 Billion in 2023 and is expected to reach USD 114.55 Billion by the end of 2036, registering around 6.1% CAGR during the forecast period i.e., between 2024-2036. Increasing awareness toward the development of novel drugs and the growing demand for drugs to cure cardiometabolic diseases are the major factors driving the growth of the market.

North America is projected to dominate majority industry share by 2036, on the back of presence of multiple key players in the region and higher prevalence of cardiovascular diseases and usage ofÃ‚Â cardiovascular devices.

GSK plc, Lupin Limited, Merck KGaA, Romark L.C., Pfizer Inc., Endo International plc, Bayer AG, Jazz Pharmaceuticals plc, Canopy Growth Corporation, InMed Pharmaceuticals Inc.

Inquiry Before Buying Request Free Sample